AD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe | Alzheimer's & dementia |  | 2022 | 242 | 91 | ||
| Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | 2021 | 213 | 65 | ||
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | | 2021 | 260 | 123 | ||
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers | European journal of nuclear medicine and molecular imaging | | 2021 | 158 | 86 | ||
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services — part 2 of 6 | Alzheimer's research & therapy | | 2021 | 96 | 28 | ||
| 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | 2021 | 162 | 89 | ||
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services — part 6 of 6 | Alzheimer's research & therapy | | 2021 | 87 | 5 | ||
| Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework | European journal of nuclear medicine and molecular imaging | | 2021 | 175 | 79 | ||
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging | | 2021 | 251 | 103 | ||
| Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | 2021 | 131 | 43 | ||
| Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study | Aging Clinical and Experimental Research |  | 2020 | 369 | 1 | ||
| Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education | Neurobiology of Aging | | 2020 | 355 | 0 | ||
| Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging | | 2020 | 343 | 6 | ||
| Short-term Sahaja Yoga meditation training modulates brain structure and spontaneous activity in the executive control network | Brain and Behavior | | 2019 | 324 | 128 | ||
| Qualitative Scoring of the Pentagon Test: A Tool for the Identification of Subtle Cognitive Deficits in Isolated REM Sleep Behavior Disorder Patients | Archives of Clinical Neuropsychology | | 2019 | 333 | 0 | ||
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging | | 2019 | 355 | 6 | ||
| The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy | NeuroImage: Clinical | | 2019 | 203 | 112 | ||
| Improving innovative decision-making: Training-induced changes in fronto-parietal networks | Brain and Cognition | | 2018 | 264 | 0 |
